MDP.TO
Medexus Pharmaceuticals Inc
Price:  
2.96 
CAD
Volume:  
12,966.00
Canada | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MDP.TO EV/EBITDA

180.5%
Upside

As of 2025-07-11, the EV/EBITDA ratio of Medexus Pharmaceuticals Inc (MDP.TO) is 4.18. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MDP.TO's latest enterprise value is 108.69 mil CAD. MDP.TO's TTM EBITDA according to its financial statements is 26.02 mil CAD. Dividing these 2 quantities gives us the above MDP.TO EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 11.2x - 16.3x 13.8x
Forward P/E multiples 12.8x - 19.0x 13.8x
Fair Price 5.45 - 12.76 8.30
Upside 84.0% - 330.9% 180.5%
2.96 CAD
Stock Price
8.30 CAD
Fair Price

MDP.TO EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-07-09 4.18
2025-07-08 4.24
2025-07-07 4.24
2025-07-04 4.36
2025-07-03 4.26
2025-07-02 4.39
2025-06-30 4.44
2025-06-27 4.41
2025-06-26 4.41
2025-06-25 4.66
2025-06-24 4.57
2025-06-23 4.72
2025-06-20 4.50
2025-06-19 4.44
2025-06-18 4.34
2025-06-17 4.26
2025-06-16 4.23
2025-06-13 4.14
2025-06-12 4.14
2025-06-11 4.16
2025-06-10 4.05
2025-06-09 4.03
2025-06-06 4.03
2025-06-05 4.10
2025-06-04 4.10
2025-06-03 4.18
2025-06-02 4.14
2025-05-30 4.33
2025-05-29 4.08
2025-05-28 4.09
2025-05-27 4.13
2025-05-26 4.15
2025-05-23 3.92
2025-05-22 3.88
2025-05-21 3.78
2025-05-20 3.71
2025-05-16 3.84
2025-05-15 3.84
2025-05-14 3.61
2025-05-13 3.72
2025-05-12 3.89
2025-05-09 4.13
2025-05-08 4.02
2025-05-07 3.72
2025-05-06 3.79
2025-05-05 3.87
2025-05-02 3.93
2025-05-01 3.98
2025-04-30 3.90
2025-04-29 3.99